The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 9 METERS BIOPHARMA INC | COM | 654405109 | 469 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
| AADI BIOSCIENCE INC | COM | 00032Q104 | 1,848 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 467 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 277 | 1,900 | SH | SOLE | 1,900 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | COM | 03152W109 | 10,740 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 10,175 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| ARVINAS INC | COM | 04335A105 | 4,630 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 6,972 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 8,618 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 3,439 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 8,088 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 2,696 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 8,118 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 4,776 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 3,850 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| DICE THERAPEUTICS INC | COM | 23345J104 | 466 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
| DICE THERAPEUTICS INC | COM | 23345J104 | 2,328 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 7,976 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 4,810 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 5,693 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,722 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 5,660 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 7,384 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 1,575 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| RAPT THERAPEUTICS INC | COM | 75382E109 | 3,011 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 4,748 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 9,745 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| SEAGEN INC | COM | 81181C104 | 6,193 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| SPDR SER TR | S&P BIOTECH | 78464A870 | 3,714 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| SPDR SER TR | S&P BIOTECH | 78464A870 | 29,708 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 4,329 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 1,752 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 7,072 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,942 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||